NanoCARE 2.0 Supports Innovative Collaborative Projects in Nanomedicine Led by Young Researchers
At NanoCARE 2.0, we take pride in supporting the work of young researchers through the “Proyectos Colaborativos Junior IP” initiative. This program fosters collaboration and innovation, enabling talented scientists to advance their research in key areas of nanotechnology and biomedical applications.
They are currently two outstanding junior collaborative projects funded through this initiative.
The COLINA project (COmbinatorial LIpid nanosystems for Nucleic Acid delivery in neuroblastoma treatment ) is a collaboration between the BioNanoMed research team led by Dr. Maria Blanco at the Faculty of Pharmacy and Nutrition of the University of Navarra and the Nanobiotechnology Group led by Dr. Alvaro Somoza at the IMDEA Nanociencia Institute. Under the leadership of Dr. Carlos Rodriguez Nogales (UNAV) and Dr. Mario Martínez Mingo (IMDEA Nanociencia), this research is focused on developing novel lipid-based nanotherapeutics for the delivery of oligonucleotides in neuroblastoma models to develop a novel nanotherapeutic approach to treat neuroblastoma, a pediatric tumor of the peripheral nervous system with very poor prognosis.
The SyNErGIC project (Synergizing Nanotechnology and Metabolic Glycoengineering for Improving Cancer Therapeutics)- a collaboration between the Nano-Oncology and Translational Therapeutic group led by Dr. Maria de la Fuente at the Health Research Institute of Santiago de Compostela, and the Bionanosurf Group led by Dr. Jesús Martinez de la Fuente, part of the Institute of Nanoscience and Materials of Aragón (INMA)—a joint research center between CSIC and the University of Zaragoza. Under the leadership of Dr. Jenifer García-Fernández (IDIS) and Dr. Raluca M. Fratila (INMA), this research explores innovative strategies at the intersection of nanotechnology and bioengineering to enhance targeted cancer therapies.
Through these collaborations, researchers have gained valuable insights into state-of-the-art techniques, fostering interdisciplinary knowledge exchange and strengthening the impact of nanomedicine in therapeutic applications.
These achievements align with NanoCARE 2.0’s mission to promote networking for scientific excellence, support emerging talent, and contribute to groundbreaking discoveries that push the boundaries of biomedical research.